학술논문

발행년
-
(예 : 2010-2015)
'학술논문' 에서 검색결과 1,631건 | 목록 1~10
Academic Journal
Buitelaar PLM; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands. Electronic address: p.buitelaar@nki.nl.; de Jong KAM; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Aardenburg L; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; van der Heijden MS; Department of Medical Oncology, Netherlands Cancer Institute, Amsterdam, the Netherlands.; Huitema ADR; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht, the Netherlands; Department of Pharmacology, Princess Maxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Beijnen JH; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands.; Rosing H; Department of Pharmacy & Pharmacology, Antoni van Leeuwenhoek Hospital, The Netherlands Cancer Institute, Amsterdam, the Netherlands.
Publisher: Elsevier Science Country of Publication: England NLM ID: 8309336 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1873-264X (Electronic) Linking ISSN: 07317085 NLM ISO Abbreviation: J Pharm Biomed Anal Subsets: MEDLINE
Academic Journal
Li W; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; The Second Affiliated Hospital of Nantong University, Shengli Rd 666, Nantong 226001, China. Electronic address: Wenlong.Li@cruk.cam.ac.uk.; Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Universiteitsweg 99, Utrecht 3584 CG, the Netherlands.; Wang Y; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Martins MLF; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; de Waart DR; Tytgat Institute for Liver and Intestinal Research, Academic Medical Center, Meibergdreef 71, Amsterdam 1105 BK, the Netherlands.; van Tellingen O; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Song JY; The Netherlands Cancer Institute, Division of Experimental Animal Pathology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Lebre MC; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; van Hoppe S; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Wagenaar E; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology & Clinical Pharmacology, Universiteitsweg 99, Utrecht 3584 CG, the Netherlands; The Netherlands Cancer Institute, Department of Pharmacy & Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.; Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Plesmanlaan 121, Amsterdam 1066 CX, the Netherlands.
Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Academic Journal
Rijmers J; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Retmana IA; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands.; Bui V; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Arguedas D; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Lebre MC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands.; Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, the Netherlands; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, the Netherlands.; Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands. Electronic address: a.schinkel@nki.nl.
Publisher: Editions Scientifiques Elsevier Country of Publication: France NLM ID: 8213295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1950-6007 (Electronic) Linking ISSN: 07533322 NLM ISO Abbreviation: Biomed Pharmacother Subsets: MEDLINE
Academic Journal
Embaby A; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Huijberts SCFA; Antoni van Leeuwenhoek Netherlands Cancer Institute, Amsterdam, Noord Holland, Netherlands.; Wang L; The Netherlands Cancer Institute, Amsterdam, Netherlands.; Leite de Oliveira R; Amsterdam University Medical Centers, Amsterdam, Netherlands.; Rosing H; The Netherlands Cancer Institute, Amsterdam, Netherlands, Netherlands.; Nuijen B; The Netherlands Cancer Institute, Amsterdam, Netherlands.; Sanders J; The Netherlands Cancer Institute, Amsterdam, Netherlands.; Hofland I; The Netherlands Cancer Institute,, Amsterdam, Netherlands.; van Steenis C; Netherlands Cancer Institute, Netherlands.; Kluin RJC; The Netherlands Cancer Institute, Amsterdam, Noord-Holland, Netherlands.; Lieftink C; The Netherlands Cancer Institute, Amsterdam, Netherlands.; Smith CG; NeoGenomics, Cambridge, United Kingdom.; Blank CU; Netherlands Cancer Institute, Amsterdam, Netherlands.; van Thienen JV; Netherlands Cancer Institute, Amsterdam, Netherlands.; Haanen JBAG; The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Steeghs N; Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, Netherlands.; Opdam FL; Netherlands Cancer Institute, Amsterdam, Netherlands.; Beijnen JH; Netherlands Cancer Institute, Amsterdam, Netherlands.; Huitema ADR; Netherlands Cancer Institute, Amsterdam, Netherlands.; Bernards R; The Netherlands Cancer Institute, Amsterdam, Netherlands.; Schellens JHM; Utrecht University, Utrecht, Netherlands.; Wilgenhof S; Netherlands Cancer Institute - Antoni van Leeuwenhoek, Amsterdam, Netherlands.
Publisher: The Association Country of Publication: United States NLM ID: 9502500 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1557-3265 (Electronic) Linking ISSN: 10780432 NLM ISO Abbreviation: Clin Cancer Res Subsets: MEDLINE
Academic Journal
Palić S; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Chu WY; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.; Sundar S; Department of Medicine, Banaras Hindu University, Varanasi, India.; Mondal D; Centre for Nutrition and Food Security (CNFS), International Centre for Diarrhoeal Disease Research, Bangladesh (icddr,b), Dhaka, Bangladesh.; Das P; Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India.; Pandey K; Rajendra Memorial Research Institute of Medical Sciences (RMRIMS), Patna, India.; Raja S; Drugs for Neglected Diseases initiative (DNDi) South Asia, New Delhi, India.; Rijal S; Drugs for Neglected Diseases initiative (DNDi) South Asia, New Delhi, India.; Roseboom IC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Hamadeh A; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.; Malik PRV; School of Pharmacy, University of Waterloo, Waterloo, Ontario, Canada.; Beijnen JH; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Huitema ADR; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Sjögren E; Department of Pharmaceutical Biosciences, Uppsala University, Uppsala, Sweden.; Pharmetheus AB, Uppsala, Sweden.; Alves F; Drugs for Neglected Diseases initiative (DNDi), Geneva, Switzerland.; Dorlo TPC; Department of Pharmacy & Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Publisher: Oxford University Press Country of Publication: England NLM ID: 7513617 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1460-2091 (Electronic) Linking ISSN: 03057453 NLM ISO Abbreviation: J Antimicrob Chemother Subsets: MEDLINE
Academic Journal
van der Heijden LT; Department of Pharmacology and Pharmacy, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands. l.vd.heijden@nki.nl.; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands. l.vd.heijden@nki.nl.; Department of Clinical Pharmacy, OLVG Hospital, Amsterdam, The Netherlands. l.vd.heijden@nki.nl.; Opdam FL; Department of Medical Oncology, The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Beijnen JH; Department of Pharmacology and Pharmacy, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmaco-Epidemiology and Clinical Pharmacology, Department of Pharmaceutical Sciences, Faculty of Science, Utrecht University, Utrecht, The Netherlands.; Huitema ADR; Department of Pharmacology and Pharmacy, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Division of Pharmacology, Antoni van Leeuwenhoek/The Netherlands Cancer Institute, Amsterdam, The Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.; Department of Pharmacology, Princess Maxima Center, Utrecht, The Netherlands.
Publisher: Springer France Country of Publication: France NLM ID: 7608491 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2107-0180 (Electronic) Linking ISSN: 03787966 NLM ISO Abbreviation: Eur J Drug Metab Pharmacokinet Subsets: MEDLINE
Academic Journal
Publisher: S. Karger Country of Publication: Switzerland NLM ID: 101627692 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2296-5262 (Electronic) Linking ISSN: 22965270 NLM ISO Abbreviation: Oncol Res Treat Subsets: MEDLINE
Academic Journal
Akgöl K; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; van Merendonk LN; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Barkman HJ; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; van Balen DE; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; van den Hoek HL; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Klous MG; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Hendrikx JJ; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Nuclear Medicine, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Huitema AD; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Department of Pharmacology, Princess Máxima Center for Pediatric Oncology, Utrecht, the Netherlands.; Department of Clinical Pharmacy, University Medical Center Utrecht, Utrecht University, Utrecht, the Netherlands.; Beijnen JH; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.; Nuijen B; Department of Pharmacy and Pharmacology, The Netherlands Cancer Institute-Antoni van Leeuwenhoek, Amsterdam, the Netherlands.
Publisher: SAGE Publications Country of Publication: England NLM ID: 9511372 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1477-092X (Electronic) Linking ISSN: 10781552 NLM ISO Abbreviation: J Oncol Pharm Pract Subsets: MEDLINE
Academic Journal
Loos NHC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Sparidans RW; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands.; Heydari P; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacology, Utrecht, the Netherlands.; Bui V; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Lebre MC; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands.; Beijnen JH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands; Utrecht University, Faculty of Science, Department of Pharmaceutical Sciences, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht, the Netherlands; The Netherlands Cancer Institute, Division of Pharmacy and Pharmacology, Amsterdam, the Netherlands.; Schinkel AH; The Netherlands Cancer Institute, Division of Pharmacology, Amsterdam, the Netherlands. Electronic address: a.schinkel@nki.nl.
Publisher: Academic Press Country of Publication: United States NLM ID: 0416575 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1096-0333 (Electronic) Linking ISSN: 0041008X NLM ISO Abbreviation: Toxicol Appl Pharmacol Subsets: MEDLINE
검색 결과 제한하기
제한된 항목
[AR] Beijnen JH
발행연도 제한
-
학술DB(Database Provider)
저널명(출판물, Title)
출판사(Publisher)
자료유형(Source Type)
주제어
언어